# Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)

> **NCT00000602** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Anemia, Sickle Cell
- Hematologic Diseases
- Hemoglobinopathies

## Interventions

- **DRUG:** hydroxyurea

## Key facts

- **NCT ID:** NCT00000602
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-04
- **Primary completion:** —
- **Final completion:** 1997-03
- **Target enrollment:** — (—)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000602, "Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*